This study raises pharmacovigilance signals and mechanistic hypotheses about liraglutide in people with ulcerative colitis — important because GLP-1 drugs are widely used and are being studied for inflammatory effects....

Knowing ustekinumab levels and anti-drug antibody status may help predict which people with Crohn’s disease are more likely to be in clinical remission and guide treatment adjustments.

People with IBD commonly experience mood disorders; identifying shared molecular signals could help explain why and point to biomarkers or targets for research. This study proposes three genes linked to conserved...

Modeled cost savings and fewer hospital visits could affect access to infliximab for people with Crohn’s disease and other autoimmune conditions in Jordan, potentially increasing the number of patients who can be treated...

Preclinical evidence suggests certain dietary flavonoids may protect the gut barrier, reshape the microbiome, and reduce neuroinflammation, which could be relevant to colitis-linked cognitive problems. This points to...

Standardized, automated severity stratification at diagnosis could help guide early treatment planning and comparability across centers. An AI approach that approximates expert consensus may reduce variability in initial...

This study links higher mucosal PD-L1 expression to active IBD and routine disease activity measures, suggesting the PD-1/PD-L1 immune checkpoint may be involved in intestinal inflammation and could be a biomarker or...

A reliable blood biomarker that predicts relapse while a person with UC is in remission could help tailor monitoring intensity and treatment decisions.

The study identifies a bile acid, TUDCA, that reduced colitis severity and improved gut-barrier and antioxidant pathways in mice, pointing to a potential new therapeutic approach for intestinal inflammation. This is...

Microbiological differences in Crohn’s-related abscesses could affect empirical antibiotic choices and highlight the importance of culture-directed therapy, especially in patients on immunosuppression who showed higher...

Based on the title and source metadata, this appears to be a basic science related to Inflammatory bowel disease, Microbiome, and Research and clinical trials. The original article is from Journal of genetics and...

Based on the title and source metadata, this appears to be a case report related to Ulcerative colitis, Inflammatory bowel disease, and Mesalamine. The original article is from BMJ case reports.

Adherence affects how well advanced IBD treatments work. Knowing which drug forms and patient factors link to missed doses can help patients and clinicians plan support strategies.

Depression is more common in people with Crohn’s and can worsen disease outcomes and quality of life. Recognizing and treating depression alongside Crohn’s may improve symptom control, reduce hospitalizations, and lower...

Cure8 found this source from health.usnews.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the...

Enteric hyperoxaluria increases risk of calcium oxalate kidney stones and kidney injury. Knowing how common EH is in Crohn's disease and after bariatric surgery helps identify who might benefit from screening and...

The story highlights how Crohn’s disease can require ongoing treatment and how legal and travel problems can affect access to care. It may be relevant to people with IBD who use or consider cannabis/CBD products for...

Recognition of a local IBD leader signals available specialized multidisciplinary care and ongoing clinical trials activity at UCI Health — relevant for patients seeking advanced treatment or trial participation. It also...

Internal fistulae can be clinically silent yet serious in long-standing Crohn's disease. Early cross-sectional imaging detected rare gastrocolic and duodenocolic fistulae in this patient, and elective combined surgery...

Automated, objective scoring of colonoscopy images could reduce variability in Mayo Endoscopic Score assignment and support treatment decisions and monitoring for people with ulcerative colitis.

Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Disinformation Security...

Based on the title and source metadata, this appears to be an opinion or commentary related to Crohn's disease, Perianal Disease, and Community and awareness. The original article is from Inflammatory bowel diseases.

This paper maps where and how mitochondria-related IBD research has grown and what themes (like mitophagy, metabolism, and machine learning) are emerging — useful for researchers, funders, and clinicians tracking...

These Day 1 scores aim to identify patients unlikely to respond to IV steroids so treatment can be escalated earlier; that could shorten delays to rescue therapy and potentially improve outcomes for people admitted with...

A simple blood marker (LBP) that reflects bacterial exposure across the gut barrier was linked to disease severity and immune activity at diagnosis and during follow-up—especially in ulcerative colitis—so it might help...

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Research and clinical trials. The original article is from Journal of clinical gastroenterology.

Distinguishing Crohn’s disease from appendicitis is a common and important diagnostic problem. Objective CT measurements could help reduce subjective interpretation and guide correct diagnosis, but this study shows...

A high-profile IBD specialist joining a large GI group could expand access to expert IBD care, boost local research activity, and help train new gastroenterologists—changes that may affect patients in South Florida and...

Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Journal of Food Science...

The study helps explain how granulomas—linked to more severe Crohn’s disease—might form by repurposing lymphoid follicle macrophages, pointing to cellular programs and signals that could be relevant for future biomarkers...

Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Ustekinumab. The original article is from BMC Gastroenterology.

This study supports intestinal ultrasound as a noninvasive, accurate way to detect small-bowel Crohn's activity in many pediatric patients, which could reduce reliance on MRI for routine monitoring. It highlights...

This study suggests mirikizumab can maintain endoscopic and symptomatic improvements for up to two years in many patients with Crohn’s disease, and that IV reinduction can recover response in a subset of 1-year...

Faster, more sensitive capsule endoscopy reading could catch more Crohn’s-related ulcers that might otherwise be missed and reduce the time clinicians spend reviewing long video exams. However, AI increased false...

Starting biologic therapy within six months of Crohn’s diagnosis was associated with substantially higher rates of steroid-free remission at one year and less steroid dependence, suggesting earlier treatment could...

Based on the title and source metadata, this appears to be a case report related to Crohn's disease, Inflammatory bowel disease, and Pediatrics and family. The original article is from pubmed.ncbi.nlm.nih.gov.

The piece connects a criminal harassment case to a dispute over insurance coverage for Crohn’s disease, highlighting how deeply insurance problems can affect people and those around them.

Based on the title and source metadata, this appears to be an opinion or commentary related to Inflammatory bowel disease and Medications. The original article is from Internal medicine journal.

The study is collecting genetic and clinical data to identify genes that may contribute to IBD risk across populations — information that could inform future research, risk prediction, and understanding of disease...

This national pediatric IBD network aims to collect clinical data and biological samples to study causes of early-onset IBD, track outcomes including intestinal healing and growth, and improve treatment strategies — work...

Fatigue is a common, impactful symptom in Crohn's disease with limited targeted treatments. This early-phase trial is testing whether CoQ10 supplements might reduce fatigue and could inform larger placebo-controlled...

People with UC and PSC have limited study data on microbiome-targeted therapies; this trial asks whether short-course oral vancomycin is feasible and safe in this specific group and will look for early signals in...

Adherence to biologic therapy can affect how well treatment controls IBD; understanding whether self-administered subcutaneous vedolizumab has different adherence than IV infusion could influence treatment choices and...

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease, Blood Test, and Tests and monitoring. The original article is from Canadian journal of gastroenterology &...

Noninvasive fecal tests can help detect intestinal inflammation without repeated endoscopy and support treat-to-target care. Better biomarkers could mean earlier treatment changes and less invasive monitoring for people...

This review directly addresses whether switching from originator infliximab to a biosimilar affects disease control or safety in children with IBD — a common practical concern for families and clinicians. Its pooled data...

The study documents shifting real-world prescribing for newly diagnosed IBD in Germany, with more biologic use and less mesalazine/thiopurine in recent years — changes that could affect treatment expectations and access.

The analysis suggests that some biologic and small-molecule therapies work differently depending on whether Crohn's disease affects the ileum, colon, or both — information that could help tailor long-term treatment...